The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Castle Biosciences Inc (NASDAQ: CSTL) was $26.15 for the day, down -13.55% from the previous closing price of $30.25. In other words, the price has decreased by -$13.55 from its previous closing price. On the day, 1.25 million shares were traded. CSTL stock price reached its highest trading level at $29.9 during the session, while it also had its lowest trading level at $24.6.
Ratios:
Our analysis of CSTL’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.62 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.30. For the most recent quarter (mrq), Quick Ratio is recorded 7.64 and its Current Ratio is at 7.78. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on December 14, 2023, initiated with a Buy rating and assigned the stock a target price of $25.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $54.
On January 07, 2022, Stephens started tracking the stock assigning a Overweight rating and target price of $59.Stephens initiated its Overweight rating on January 07, 2022, with a $59 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’25 when BRADBURY DANIEL sold 7,867 shares for $29.14 per share. The transaction valued at 229,226 led to the insider holds 1,425 shares of the business.
MAETZOLD DEREK J sold 4,343 shares of CSTL for $128,637 on Jan 06 ’25. The Pres. & Chief Exec. Officer now owns 5,291 shares after completing the transaction at $29.62 per share. On Jan 06 ’25, another insider, MAETZOLD DEREK J, who serves as the Pres. & Chief Exec. Officer of the company, sold 2,715 shares for $29.62 each. As a result, the insider received 80,412 and left with 82,047 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CSTL now has a Market Capitalization of 847220736 and an Enterprise Value of 479345920. As of this moment, Castle’s Price-to-Earnings (P/E) ratio for their current fiscal year is 130.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.35 while its Price-to-Book (P/B) ratio in mrq is 1.66. Its current Enterprise Value per Revenue stands at 1.537 whereas that against EBITDA is 38.61.
Stock Price History:
The Beta on a monthly basis for CSTL is 0.89, which has changed by 0.5616933 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, CSTL has reached a high of $35.84, while it has fallen to a 52-week low of $16.97. The 50-Day Moving Average of the stock is -12.93%, while the 200-Day Moving Average is calculated to be -0.05%.
Shares Statistics:
CSTL traded an average of 392.86K shares per day over the past three months and 364410 shares per day over the past ten days. A total of 27.98M shares are outstanding, with a floating share count of 27.14M. Insiders hold about 3.11% of the company’s shares, while institutions hold 92.00% stake in the company. Shares short for CSTL as of 1734048000 were 1681009 with a Short Ratio of 4.21, compared to 1731628800 on 1707849. Therefore, it implies a Short% of Shares Outstanding of 1681009 and a Short% of Float of 6.1899999999999995.
